Clinical Trial Update: CSPPT- Chronic Kidney Diseases Study [Phase 4]

View source ↗

Summary

Phase 4 CSPPT Chronic Kidney Diseases Study has been withdrawn by the sponsor; the trial evaluated treatment in hypertensive patients with hyperhomocysteinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperhomocysteinemia
• Hypertension

Drugs mentioned

• CSPPT

Snippet

Sponsor: Shenzhen Ausa Pharmed Co.,Ltd | Conditions: Hypertension, Hyperhomocysteinemia | Phase 4 | Status: WITHDRAWN